Portomesenteric Vein Thrombosis in Patients Undergoing Sleeve Gastrectomy: an Updated Systematic Review and Meta-Analysis of 101,914 Patients

D Giannis, G Geropoulos, CD Kakos, W Lu… - Obesity Surgery, 2023 - Springer
Introduction Portomesenteric vein thrombosis (PMVT) is a rare but potentially fatal
complication of sleeve gastrectomy (SG). The rising prevalence of SG has led to a surge in …

Obese patients with atrial fibrillation are more efficiently protected from thrombosis under warfarin or xabans compared to non-obese patients; a systematic review and …

L Karatisidis, K Zagoridis, T Mprotsis, C Misidou… - Thrombosis …, 2024 - Elsevier
Introduction Recommendations about proper anticoagulation in obese patients, body mass
index (BMI)> 30 kg/m2, are not yet clearly defined. Obese patients were included in …

Real life results of direct-acting oral anticoagulants recommended-dose in obese vs normal-weight patients with venous thromboembolism

JA Rueda-Camino, R Barba, S Otálora… - Thrombosis …, 2024 - Elsevier
Background There is scarce evidence on the effectiveness and safety of recommended-
dose direct acting oral anticoagulants (DOACs) in obese patients with venous …

Documentation of the Patient Characteristics Morbid Obesity and Bariatric Surgery in the Hospital Information System and the Influence on the Number of Medication …

JS Kingma, IAM Brenkman… - Annals of …, 2024 - journals.sagepub.com
Background: As a result of pharmacokinetic changes, individuals with morbid obesity and/or
with bariatric surgery may require dose adjustments, additional monitoring or medication …

Practical Issues with Using Direct Oral Anticoagulant After Bariatric Metabolic Surgery

M Hany, AML Bedewy, B Torensma - Obesity Surgery, 2023 - Springer
Post-Discharge Prophylaxis with Rivaroxaban Prevents Porto-Mesenteric Venous
Thrombosis Following Laparoscopic Sleeve Gastrectomy with great interest [1]. Swarts et al …

[HTML][HTML] Effectiveness and safety of non-vitamin K antagonist oral anticoagulant in the treatment of patients with morbid obesity or high body weight with venous …

H Zhang, H Xie, X Wang, Z Zhu, F Duan - Medicine, 2023 - journals.lww.com
Background: Venous thromboembolism (VTE) poses a significant health risk to patients with
morbid obesity or high body weight. Non-vitamin K antagonist oral anticoagulants (NOACs) …

RE: Letter to the Editor “Practical Issues with Using Direct Oral Anticoagulant After Bariatric Metabolic Surgery” Following the Publication of:“30-Day Post-Discharge …

DE Swartz, S Gupta - Obesity Surgery, 2023 - Springer
We would like to thank Professor Hany and his coauthors for their thoughtful and well-
referenced critique of our study [1]. Indeed, they raise many important points that we feel …